[Complete bone marrow suppression and megaloblastic anemia as a result of long-term treatment with cotrimoxazole].
D000748:Anemia, Macrocytic / Q000139:chemically induced*; D000749:Anemia, Megaloblastic / Q000139:chemically induced*; D001853:Bone Marrow / Q000187:drug effects*; D004338:Drug Combinations; D006801:Humans; D008297:Male; D008875:Middle Aged; D011704:Pyelonephritis / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000009:adverse effects* / Q000627:therapeutic use; D014295:Trimethoprim / Q000009:adverse effects* / Q000627:therapeutic use
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole
Pełne uszkodzenie szpiku i niedokrwistość megaloblastyczna nako nastepstwo długotrwałego podawania kotrimoksazolu.